SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $276 | -98.6% | 2 | -98.7% | 0.00% | -100.0% |
| Q4 2022 | $19,826 | +147.8% | 153 | +57.7% | 0.00% | +200.0% |
| Q1 2022 | $8,000 | -11.1% | 97 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $9,000 | 0.0% | 97 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $9,000 | +28.6% | 97 | +2.1% | 0.00% | 0.0% |
| Q2 2021 | $7,000 | – | 95 | +2275.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 4 | -96.2% | 0.00% | -100.0% |
| Q4 2020 | $18,000 | +20.0% | 104 | 0.0% | 0.01% | +33.3% |
| Q3 2020 | $15,000 | -11.8% | 104 | 0.0% | 0.01% | -14.3% |
| Q2 2020 | $17,000 | +70.0% | 104 | 0.0% | 0.01% | +40.0% |
| Q1 2020 | $10,000 | -23.1% | 104 | +4.0% | 0.01% | 0.0% |
| Q4 2019 | $13,000 | – | 100 | +3233.3% | 0.01% | – |
| Q1 2019 | $0 | -100.0% | 3 | -72.7% | 0.00% | -100.0% |
| Q3 2018 | $2,000 | – | 11 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |